Teva stock is at its highest level in nearly a decade. Here's why it could soar even more.

The market's rediscovery of Teva Pharmaceuticals remains ongoing.

Wall Street thinks Teva stock still has room to run after soaring over 100%. Here's why analysts are right.

Teva's turnaround is real -- and may not be over.
Nasdaq

TEVA Stock Up Around 13% in a Month: Buy, Sell or Hold the Stock?

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter results were ...
AOL

Teva Pharmaceutical's Turnaround Is Working. Here's When to Buy the Stock.

Teva Pharmaceutical Industries (NYSE: TEVA) will unveil its first-quarter results this Wednesday, April 29. Many Teva trackers will be watching for validation of the company's continuing strategic ...
Nasdaq

TEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock?

Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has successfully launched several biosimilars and other high-value, complex ...

Teva Pharmaceutical Industries Limited Sponsored ADR

View Teva Pharmaceutical Industries Limited Sponsored ADR TEVA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Yahoo Finance

Teva Stock Is at Its Highest Level in Nearly a Decade. Here's Why It Could Soar Even More.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
AOL

Teva Stock Is at Its Highest Level in Nearly a Decade. Here's Why It Could Soar Even More.

It's no longer a secret that the Teva Pharmaceutical Industries (NYSE: TEVA) of the past is no more. The Israel-based company is no longer strictly a generic-drug maker, burdened by heavy debt and ...